Compare Nippon India Pharma Fund vs ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund
Risk
Very High
Very High
Rating
3.0
5.0
Min SIP Amount
₹100
₹100
Expense Ratio
1.81
1.86
NAV
₹510.69
₹37.96
Fund Started
10 May 2004
25 Jun 2018
Fund Size
₹7875.40 Cr
₹6658.41 Cr
Exit Load
Exit load of 1% if redeemed within 1 month.
Exit load of 1% if redeemed within 15 days.
1 Year
9.01%
8.03%
3 Year
23.77%
27.09%
5 Year
15.54%
16.93%
Equity
98.96%
97.60%
Cash
1.04%
2.37%
Top 10 Holdings
Sun Pharmaceutical Industries Ltd. | 12.67% |
Lupin Ltd. | 7.88% |
Divi's Laboratories Ltd. | 6.54% |
Dr. Reddy's Laboratories Ltd. | 6.06% |
Cipla Ltd. | 5.88% |
Apollo Hospitals Enterprise Ltd. | 5.73% |
Medplus Health Services Ltd. | 3.68% |
Vijaya Diagnostic Centre Ltd. | 3.51% |
Ajanta Pharma Ltd. | 3.39% |
Glaxosmithkline Pharmaceuticals Ltd. | 2.78% |
Sun Pharmaceutical Industries Ltd. | 11.20% |
Cipla Ltd. | 9.43% |
Dr. Reddy's Laboratories Ltd. | 7.27% |
Mankind Pharma Ltd. | 6.34% |
Divi's Laboratories Ltd. | 6.22% |
Biocon Ltd. | 5.85% |
Lupin Ltd. | 4.80% |
Aurobindo Pharma Ltd. | 3.91% |
Syngene International Ltd. | 2.99% |
Alkem Laboratories Ltd. | 2.90% |
Name
-
-
Start Date
-
-
Description
The scheme seeks to generate consistent returns by investing in equity / equity related or fixed income securities of pharma and other associated companies.
The scheme seeks to generate long-term capital appreciation by creating a portfolio that is invested in equity and equity related securities of pharma, healthcare, hospitals, diagnostics, wellness and allied companies.
Launch Date
10 May 2004
25 Jun 2018
